Patent details

LUC00333 Product Name: Gefapixant, ou un sel pharmaceutiquement acceptable de celui-ci

Basic Information

Publication number:
LUC00333
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP057155582
Legal Status:
Active
Application number:
LUC00333
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/21/1613
Marketing Authorization Type:
Marketing Authorization Date:
20/09/2023
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
14/03/2024
First Marketing Authorization date:
20/09/2023
Grant date:
04/10/2024
Activation date:
25/02/2025
Publication date:
14/03/2024
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
25/02/2030
SPC Extension Expiration:
25/02/2030
Rejection date:
Withdrawal date:

Owner

From:
14/03/2024
 
 

Name:
F.Hoffmann-La Roche AG
Address:
Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
14/03/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2024/05
Publication date:
03/04/2024
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2024/13
Publication date:
05/11/2024
Description:
Section D : Granted supplementary protection certificates – I2 publication

3

Bulletin Heading:
SPC3
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
01/03/2027
Annual Fee Number:
23
Annual Fee Amount:
430 Euro
Expected Payer:
Last Annual Fee Payment Date:
18/12/2025
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
420 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
04/10/2024 Certificate 1
04/10/2024 Publication 1
04/10/2024 Outgoing Correspondence 1
14/03/2024 Application Form 3
14/03/2024 Marketing authorization 3
14/03/2024 Summary of the product caracteristics 31
14/03/2024 MA publication 3
14/03/2024 Publication 1
14/03/2024 Outgoing Correspondence 1